Get started
TRANSGENIC GROUP INCTRANSGENIC GROUP INCTRANSGENIC GROUP INC

TRANSGENIC GROUP INC

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

2342 chart


Full chart

2342 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.00 B‬ JPY
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−14 JPY
Net income (FY)
‪4.08 M‬ JPY
Revenue (FY)
‪13.08 B‬ JPY
Shares float
‪15.03 M‬
Beta (1Y)
0.38

Employees


Employees (FY)
236
Change (1Y)
0
Revenue / Employee (1Y)
‪55.44 M‬ JPY
Net income / Employee (1Y)
‪17.31 K‬ JPY

About TRANSGENIC GROUP INC


Sector
Health Technology
Industry
Biotechnology
Headquarters
Fukuoka
Website
transgenic.co.jp
Founded
1998
ISIN
JP3635720000
FIGI
BBG000BLMV98
Trans Genic Group, Inc. engages in the development, distribution, and licensing of genetically engineered animals and antibodies. It operates through the following segments: Drug Discovery Support Business and Investment and Consulting Business. The Drug Discovery Support Business segment provides seamless services that can handle all stages of drug discovery, from the initial stages of exploratory basic research and drug discovery research to non-clinical trials and clinical trials. The Investment and Consulting Business segment provides advice and support services related to the promotion of new businesses and includes retail and wholesale of electrical products, B2C and B2B. The company was founded on April 21, 1998 and is headquartered in Kumamoto, Japan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 2342 is 178 JPY — it has decreased by −1.11% in the past 24 hours. Watch TRANSGENIC GROUP INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange TRANSGENIC GROUP INC stocks are traded under the ticker 2342.
2342 stock has fallen by −7.77% compared to the previous week, the month change is a −11.44% fall, over the last year TRANSGENIC GROUP INC has showed a −29.37% decrease.
2342 reached its all-time high on Feb 4, 2003 with the price of 2,970 JPY, and its all-time low was 0.67 JPY and was reached on Sep 26, 2006. View more price dynamics on 2342 chart.
See other stocks reaching their highest and lowest prices.
2342 stock is 2.26% volatile and has beta coefficient of 0.38. Track TRANSGENIC GROUP INC stock price on the chart and check out the list of the most volatile stocks — is TRANSGENIC GROUP INC there?
Today TRANSGENIC GROUP INC has the market capitalization of ‪2.96 B‬, it has decreased by −5.67% over the last week.
Yes, you can track TRANSGENIC GROUP INC financials in yearly and quarterly reports right on TradingView.
TRANSGENIC GROUP INC is going to release the next earnings report on Feb 7, 2025. Keep track of upcoming events with our Earnings Calendar.
2342 net income for the last quarter is ‪−82.83 M‬ JPY, while the quarter before that showed ‪−99.43 M‬ JPY of net income which accounts for 16.69% change. Track more TRANSGENIC GROUP INC financial stats to get the full picture.
As of Dec 22, 2024, the company has 236.00 employees. See our rating of the largest employees — is TRANSGENIC GROUP INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TRANSGENIC GROUP INC EBITDA is ‪65.06 M‬ JPY, and current EBITDA margin is 1.94%. See more stats in TRANSGENIC GROUP INC financial statements.
Like other stocks, 2342 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRANSGENIC GROUP INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TRANSGENIC GROUP INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TRANSGENIC GROUP INC stock shows the strong sell signal. See more of TRANSGENIC GROUP INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.